BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26462774)

  • 21. [Expression of PRAME gene in adult acute leukemia and its significance in prognosis].
    Zhou PY; Li WJ; Wei CX; Zhou Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1177-81. PubMed ID: 18088461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of histone demethylase lysine specific demethylase 1 in acute leukemia and its clinical significance].
    Lin XM; Zhong WT; Wang CL; Wang SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1348-52. PubMed ID: 22169281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia.
    Tzoneva G; Dieck CL; Oshima K; Ambesi-Impiombato A; Sánchez-Martín M; Madubata CJ; Khiabanian H; Yu J; Waanders E; Iacobucci I; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Kirschner-Schwabe R; Mullighan CG; Rabadan R; Ferrando AA
    Nature; 2018 Jan; 553(7689):511-514. PubMed ID: 29342136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia.
    Dieck CL; Tzoneva G; Forouhar F; Carpenter Z; Ambesi-Impiombato A; Sánchez-Martín M; Kirschner-Schwabe R; Lew S; Seetharaman J; Tong L; Ferrando AA
    Cancer Cell; 2018 Jul; 34(1):136-147.e6. PubMed ID: 29990496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.
    Mitra AK; Crews KR; Pounds S; Cao X; Feldberg T; Ghodke Y; Gandhi V; Plunkett W; Dolan ME; Hartford C; Raimondi S; Campana D; Downing J; Rubnitz JE; Ribeiro RC; Lamba JK
    J Pharmacol Exp Ther; 2011 Oct; 339(1):9-23. PubMed ID: 21712425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and Significance of PTEN and BCL-2 in Acute Myeloid Leukemia].
    Sun JY; Mu N; Mu J; Li W; Zhang CG; Wang DM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):121-125. PubMed ID: 29397829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.
    Tembhare PR; Ghogale S; Ghatwai N; Badrinath Y; Kunder N; Patkar NV; Bibi AR; Chatterjee G; Arora B; Narula G; Banawali S; Deshpande N; Amare P; Gujral S; Subramanian PG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):100-111. PubMed ID: 27718302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
    Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
    Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of thioredoxin-2 for monitoring minimal residual disease in acute leukemia].
    Luo Q; Huang Z; Luo L; Xiao D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):383-7. PubMed ID: 23645238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.
    Willekens C; Blanchet O; Renneville A; Cornillet-Lefebvre P; Pautas C; Guieze R; Ifrah N; Dombret H; Jourdan E; Preudhomme C; Boissel N;
    Haematologica; 2016 Mar; 101(3):328-35. PubMed ID: 26635039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of Gli1 in Adult Acute Lymphoblastic Leukemia and Its Clinical Significance].
    Long B; Zhang XZ; Li XD; Long ZJ; Wang XZ; Liu JJ; Lin DJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):946-9. PubMed ID: 26314423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and Significance of PD-L1, HSP90 and HSP90α in Serum of Patients with Acute Leukemia].
    Ma XJ; Zhang FH; Sun L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1384-1389. PubMed ID: 29070112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of
    Moriyama T; Liu S; Li J; Meyer J; Zhao X; Yang W; Shao Y; Heath R; Hnízda A; Carroll WL; Yang JJ
    Mol Cancer Ther; 2019 Oct; 18(10):1887-1895. PubMed ID: 31358663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hTERT mRNA levels by real-time RT-PCR in acute myelogenous leukemia.
    Huh HJ; Huh JW; Yoo ES; Seong CM; Lee M; Hong KS; Chung WS
    Am J Hematol; 2005 Aug; 79(4):267-73. PubMed ID: 16044449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Real-time quantitative detection of E2A-PBX1 fusion gene in children with acute lymphoblastic leukemia and its clinical application in minimal residual disease monitoring].
    Zhang R; Liao J; Li G; Sun HQ; Shi YJ; Yang JY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):440-3. PubMed ID: 23791058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of zinc finger protein X-linked in childhood B lineage acute lymphoblastic leukemia].
    Wang Z; Liang HH; Li BS; Huang XH; Zhang J; Wang X; Ding LX; Jiang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):509-13. PubMed ID: 23866268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.